Overview
- 19 FDA inspections are on record.
- 7 inspections produced a Form 483.
- The most recent recorded inspection date is 2022-04-14.
At a glance
Inspections
19
Form 483s
7
EIRs
1
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 6 Apr 2022 – 14 Apr 2022 | Human Drugs | 483 | View 483 → |
| 3 Feb 2020 – 10 Feb 2020 | Human Drugs | Clean | |
| 21 Nov 2017 – 22 Nov 2017 | Foods & Cosmetics | Clean | |
| 14 Aug 2017 – 15 Aug 2017 | Human Drugs | Clean | |
| 15 Nov 2016 – 9 Dec 2016 | Human Drugs | Clean | |
| 13 Jun 2016 – 16 Jun 2016 | Foods & Cosmetics | Clean | |
| 19 Dec 2014 – 8 Jan 2015 | Human Drugs | Clean | |
| 26 Nov 2013 – 4 Dec 2013 | Human Drugs | 483 | View 483 → |
| 4 Apr 2013 – 8 Apr 2013 | Human Drugs | Clean | |
| 28 Jan 2013 – 7 Feb 2013 | Human Drugs | 483 | View 483 → |
| 25 Jan 2012 | Not recorded | 483 | View 483 → |
| 20 May 2011 | Not recorded | WL | View 483 → |
Observations on record
Form 483 observations cited at this site, most recent first.
14 Apr 2022
21 CFR 211.58
Buildings not maintained in good state of repair
Cited by Bijoy Panicker, Brandy N Lepage
14 Apr 2022
21 CFR 211.58
Buildings not maintained in good state of repair
Cited by Bijoy Panicker, Brandy N Lepage
14 Apr 2022
21 CFR 211.67(a)
Cleaning / Sanitizing / Maintenance
Cited by Bijoy Panicker, Brandy N Lepage
14 Apr 2022
21 CFR 211.67(a)
Cleaning / Sanitizing / Maintenance
Cited by Bijoy Panicker, Brandy N Lepage
Investigators
FDA investigators tied to this site in the record.
Alice S Tsao3 insp.
Robert C Steyert2 insp.
Paul C Mouris2 insp.
Bijoy Panicker1 insp.
Brandy N Lepage1 insp.
Rachael A Moliver1 insp.
Tracy M Portelli1 insp.
Karen L Kosar1 insp.
Yuyan Liang1 insp.
Christian Parra1 insp.
Charisse K Green1 insp.
Robert C Horan1 insp.
Thomas J Mooney1 insp.
Michael A Charles1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.67(a) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.100(b) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.110(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.111 | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.198(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.58 | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.100(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.142(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.160(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.166(a)(3) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.204 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.25(a) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Contract Pharmacal Corp.'s 7 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat